Chorioallantoic Membrane
Allantois
Chorion
Chick Embryo
Extraembryonic Membranes
Neovascularization, Physiologic
Allantoin
Neovascularization, Pathologic
Angiogenesis Inhibitors
Angiogenesis Inducing Agents
Membranes
Endothelium, Vascular
Membrane Lipids
Cell Membrane
Vascular Endothelial Growth Factor A
Chickens
Fibroblast Growth Factor 2
Intracellular Membranes
Oviparity
Membrane Potentials
Cell Movement
Endothelial Cells
Membranes, Artificial
Blood Vessels
Variola virus
Cells, Cultured
Quail
Umbilical Veins
Human Umbilical Vein Endothelial Cells
Cell Division
Poxviridae
Coturnix
Placenta
Cattle
Orthomyxoviridae
Erythrocyte Membrane
Membrane Fluidity
Microscopy, Electron
Endothelial Growth Factors
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factors
Neoplasms, Experimental
Lymphokines
Placentation
Cell Membrane Permeability
Viviparity, Nonmammalian
Basement Membrane
Mice, Nude
Ribonuclease, Pancreatic
Histocytochemistry
Collagen Type XVIII
Immunohistochemistry
Laminin
Melanoma, Experimental
Carcinoma, Lewis Lung
Xenograft Model Antitumor Assays
Dose-Response Relationship, Drug
Models, Biological
Signal Transduction
Culture Techniques
Receptors, Vitronectin
Calcium
Blotting, Western
Neoplasm Transplantation
Collagen
Molecular Sequence Data
Amino Acid Sequence
Tumor Cells, Cultured
Rabbits
Morphogenesis
Integrin alphaVbeta3
Peptide Fragments
Membrane Transport Proteins
Organ Culture Techniques
Drug Combinations
Matrix Metalloproteinase Inhibitors
Neoplasm Metastasis
Embryo, Nonmammalian
Growth Substances
RNA, Messenger
Transfection
Lipid Bilayers
Cricetinae
Disease Models, Animal
Urokinase-Type Plasminogen Activator
Cornea
Biological Assay
Vascular Endothelial Growth Factor Receptor-1
Apoptosis
Yolk Sac
Peptides
Endothelium
Mitochondrial Membranes
Neoplasms
Cell Differentiation
Culture Media, Conditioned
Chemotaxis
Protein Transport
Carrier Proteins
Synaptic Membranes
Inhibitory effects of 9-(4-thio-beta-D-ribo-pentofuranosyl)guanine on tumor growth and angiogenesis. (1/287)
BACKGROUND: To find a nucleoside with anti-angiogenic activity, we tried to screen an active compound from our nucleoside library. MATERIALS AND METHODS: The compound inhibiting the growth of human umbilical vein endothelial cell (HUVEC) induced by the conditioned medium of lung carcinoma cell line PC-9 was screened. The antitumor activity of the compound was evaluated against murine sarcoma S-180 implanted onto chick embryo chorioallantoic membrane (CAM). RESULTS: 9-(4-Thio-beta-D-ribo-pentofuranosyl)guanine (4'-thioguanosine) was found to be a potent inhibitor of the growth of HUVEC. The growth of S-180 implanted onto CAM was also inhibited by 4'-thioguanosine whereas the in vitro growth of S-180 was not inhibited. The administration of 4'-thioguanosine in mice caused unexpected side effect which suggested neurotoxicity. CONCLUSIONS: Antitumor effect of 4'-thioguanosine on S-180 was suggested to be due to inhibition of tumor angiogenesis. Because of toxicity of 4'-thioguanosine in mice, further development of the derivatives which have lower toxicity is required. (+info)Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. (2/287)
The effects of thyroid hormone analogues on modulation of angiogenesis have been studied in the chick chorioallantoic membrane model. Generation of new blood vessels from existing vessels was increased 3-fold by either l-thyroxine (T4; 10(-7) mol/L) or 3,5,3'-triiodo-l-thyronine (10(-9) mol/L). T4-agarose reproduced the effects of T4, and tetraiodothyroacetic acid (tetrac) inhibited the effects of both T4 and T4-agarose. Tetrac itself was inactive and is known to block actions of T4 on signal transduction that are initiated at the plasma membrane. T4 and basic fibroblast growth factor (FGF2) were comparably effective as inducers of angiogenesis. Low concentrations of FGF2 combined with submaximal concentrations of T4 produced an additive angiogenic response. Anti-FGF2 inhibited the angiogenic effect of T4. The proangiogenic effects of T4 and FGF2 were blocked by PD 98059, a mitogen-activated protein kinase (MAPK) pathway inhibitor. Endothelial cells (ECV304) treated with T4 or FGF2 for 15 minutes demonstrated activation of MAPK, an effect inhibited by PD 98059 and the protein kinase C inhibitor CGP41251. Reverse transcription-polymerase chain reaction of RNA extracted from endothelial cells treated with T4 revealed increased abundance of FGF2 transcript at 6 to 48 hours, and after 72 hours, the medium of treated cells showed increased FGF2 content, an effect inhibited by PD 98059. Thus, thyroid hormone is shown to be a proangiogenic factor. This action, initiated at the plasma membrane, is MAPK dependent and mediated by FGF2. (+info)Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis. (3/287)
AIM: To investigate the inhibitory effects of endostatin-vascular endothelial growth inhibitor (VEGI151) recombinant adenoviruses on neovascularization. METHODS: We used recombinant adenoviruses to treat human vascular endothelial cell line ECV304, human hepatocellular carcinoma cell line HepG2, and murine fibroblast cell line L929, in order to study the chimeric gene expression in these cell lines. Chick choriallantic membrane (CAM) model, rabbit inflammatory corneal neovascularization (CNV) model, and liver cancer-bearing nude mice model were employed to investigate the negative biological effect of fusion molecules on neovascularization in vivo. RESULTS: Western blot showed that the molecular weight of fusion protein was about 41 kD after infection of ECV304, HepG2 and L929 cells with supernatant of AdhENDO-VEGI151. The fusion protein showed a specific inhibitory effect on the proliferation of ECV304 cells, but no inhibitory effect on the growth of HepG2 and L929 cells (F=13112.13, P=0.0001). In the chick choriallantic membrane (CAM) assay, the expressed fusion protein significantly inhibited neovascularization. Rabbit inflammatory corneal neovascularization (CNV) induced by intrastromal sutures resulted in a uniform neovascular response. In this model, direct subconjunctival injection of AdhENDO-VEGI151 expressed the fusion protein in vivo and suppressed the development of CNV. Topical application of AdhENDO-VEGI151 led to a significant suppression of CNV (F=1413.11, P=0.0001), as compared with the control group of AdLacZ. Immunohistochemical staining showed the fusion protein dominantly expressed in corneal epithelium. Compared with the control group of AdLacZ (4075.9+/-1849.9 mm(3)), the average tumor size of group AdhENDO-VEGI151 reduced in size (487.7+/-241.2 mm(3)) (F=14.80, P=0.0085), with an inhibition rate of 88.03%. Immunohistochemical staining showed the adenoviruses carried the fusion gene expressed on liver cancer cell membrane. MVD decreased more significantly in treated mice (30.75+/-3.31%) than in AdLacZ control (50.25+/-8.65%) (F=17.72, P=0.0056) with an inhibition rate of 39%. CONCLUSION: Fusion protein expressed by recombinant adenoviruses has a significant inhibitory effect on neovascularization. (+info)Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. (4/287)
Angiogenesis, the growth of new blood vessels, is a complex biological process that is orchestrated by several growth factors and components of the extracellular matrix, including fibronectin (FN) and its receptor the integrin alpha5beta1. Angiogenesis is a critical part of inflammation and wound repair, but the mechanism by which vascular proliferation and migration is regulated by inflammatory cells is not completely understood. We have previously shown that human neutrophil peptides (HNPs), also known as alpha-defensins, which are secreted in high concentrations when neutrophils are activated, bind specifically to FN in the extracellular matrix and inhibit plasminogen activation. Therefore, we asked whether HNPs act as a link between inflammation and angiogenesis. Alpha5beta1-mediated endothelial cell adhesion and migration to FN, both under control conditions and under stimulation by vascular endothelial growth factor (VEGF), were inhibited specifically and in a dose-dependent manner by HNPs, whereas endothelial cell adhesion and migration to other components of the extracellular matrix, such as vitronectin, collagen, or fibrinogen/fibrin were not. Consistent with this finding, HNPs bound to and promoted the binding of fibronectin to alpha5beta1 integrin in arginine-glycine-aspartic acid (RGD)-independent manner. HNPs also completely inhibited VEGF-induced proliferation and induced apoptosis of endothelial cells in a dose-dependent manner. Moreover, HNPs inhibited capillary tube formation in three-dimensional fibrin-matrices as well as neovascularization in vivo in the chicken chorioallantoic membrane assay. Taken together, these data indicate that HNPs can regulate angiogenesis by affecting endothelial cell adhesion and migration in an FN-dependent manner as well as endothelial cell proliferation. These findings provide new insight into the role of inflammatory cells in angiogenesis and might provide a platform for developing a novel class of anti-angiogenesis drugs. (+info)Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. (5/287)
BACKGROUND: Matrix metalloproteinases (MMPs) are essential for extracellular matrix remodelling and may contribute to the development of endometriosis. Transplantation of endometrium onto the chicken chorioallantoic membrane (CAM) results in endometriosis-like lesion formation, a process that requires extensive tissue remodelling. We investigated the expression of a wide range of MMPs in menstrual endometrium, endometriosis-like lesions in CAMs, in peritoneal endometriosis and in endometriosis in the rectovaginal space, as well as the function of MMPs in early lesion formation in the CAM model. METHODS: Expression of MMPs was evaluated by immunohistochemistry and MMP function was studied in the CAM by inhibiting MMP activity during lesion formation. RESULTS: Nearly all MMPs were present in all tissues studied. No significant differences in the expression of a majority of MMPs were found in endometriosis-like lesions in CAMs when compared with human endometriosis. Inhibition of MMP-1, -2, -3, -7 and -13 activities significantly impaired endometriosis-like lesion formation in CAMs. CONCLUSIONS: The MMP expression profiles of experimentally induced endometriosis in CAMs and human endometriosis are similar. The prevention of endometriosis-like lesion formation in the CAM by inhibiting MMP activity strongly suggests that MMPs have a function in the early development of endometriotic lesions. (+info)Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. (6/287)
OBJECTIVE: Low-molecular-weight heparin (LMWH) exerts antitumor activity in clinical trials. The K5 polysaccharide from Escherichia coli has the same structure as the heparin precursor. Chemical and enzymatic modifications of K5 polysaccharide lead to the production of biotechnological heparin-like compounds. We investigated the fibroblast growth factor-2 (FGF2) antagonist and antiangiogenic activity of a series of LMW N,O-sulfated K5 derivatives. METHODS AND RESULTS: Surface plasmon resonance analysis showed that LMW-K5 derivatives bind FGF2, thus inhibiting its interaction with heparin immobilized to a BIAcore sensor chip. Interaction of FGF2 with tyrosine-kinase receptors (FGFRs), heparan sulfate proteoglycans (HSPGs), and alpha(v)beta3 integrin is required for biological response in endothelial cells. Similar to LMWH, LMW-K5 derivatives abrogate the formation of HSPG/FGF2/FGFR ternary complexes by preventing FGF2-mediated attachment of FGFR1-overexpressing cells to HSPG-bearing cells and inhibit FGF2-mediated endothelial cell proliferation. However, LMW-K5 derivatives, but not LMWH, also inhibit FGF2/alpha(v)beta3 integrin interaction and consequent FGF2-mediated endothelial cell sprouting in vitro and angiogenesis in vivo in the chick embryo chorioallantoic membrane. CONCLUSIONS: LMW N,O-sulfated K5 derivatives affect both HSPG/FGF2/FGFR and FGF2/alpha(v)beta3 interactions and are endowed with FGF2 antagonist and antiangiogenic activity. These compounds may provide the basis for the design of novel LMW heparin-like angiostatic compounds. (+info)X-rays affect the expression of genes involved in angiogenesis. (7/287)
BACKGROUND: We have previously shown, using the chicken embryo chorioallantoic membrane (CAM) model of in vivo angiogenesis, that X-rays act on the extracellular matrix and enhance normal and tumor-induced angiogenesis. In the present work, we studied the effect of X-rays on the gene expression of three proteins that are important regulators of angiogenesis: vascular endothelial growth factor (VEGF), heparin affin regulatory peptide (HARP) and inducible nitric oxide synthase (iNOS). MATERIALS AND METHODS: An area of 1 cm2 of the CAM, restricted by a plastic ring was irradiated at room temperature. The expression of the genes was studied using RT-PCR and the amounts of the mRNAs were quantified using image analysis of the corresponding agarose gels of the RT-PCR products. RESULTS: VEGF mRNA was decreased 6 h after irradiation. However, at later time points, VEGF expression was significantly increased compared with the nonirradiated tissue. Similarly, X-rays down-regulated both HARP and iNOS expression 6 h after irradiation and the effect was reversed at later time points, similarly to the effect of X-rays on VEGF. CONCLUSION: These data support the notion that X-rays increase the expression of genes that favor angiogenesis. (+info)Angiogenic response induced by acellular aortic matrix in vivo. (8/287)
In this study, we investigated the angiogenic response induced by acellular aortic matrices implanted in vivo onto the chick embryo chorioallantoic membrane (CAM), a useful model for such investigation. Results showed that acellular matrices were able to induce a strong angiogenic response comparable to that of fibroblast growth factor 2 (FGF-2), a well-known angiogenic cytokine. The angiogenic response was further increased when exogenous FGF-2 or transforming growth factor beta 1 (TGF-beta1) were added to the matrices and inhibited by the addition of an anti-FGF-2 or anti-TGF-beta1 antibodies. The response may be considered dependent on a direct angiogenic effect exerted by the matrices and in part also by the presence of FGF-2 and TGF-beta1 in the acellular matrices. (+info)Pathologic neovascularization can be seen in a variety of conditions, including cancer, diabetic retinopathy, and age-related macular degeneration. In cancer, for example, the formation of new blood vessels can help the tumor grow and spread to other parts of the body. In diabetic retinopathy, the growth of new blood vessels in the retina can cause vision loss and other complications.
There are several different types of pathologic neovascularization, including:
* Angiosarcoma: a type of cancer that arises from the cells lining blood vessels
* Hemangiomas: benign tumors that are composed of blood vessels
* Cavernous malformations: abnormal collections of blood vessels in the brain or other parts of the body
* Pyogenic granulomas: inflammatory lesions that can form in response to trauma or infection.
The diagnosis of pathologic neovascularization is typically made through a combination of physical examination, imaging studies (such as ultrasound, CT scans, or MRI), and biopsy. Treatment options vary depending on the underlying cause of the condition, but may include medications, surgery, or radiation therapy.
In summary, pathologic neovascularization is a process that occurs in response to injury or disease, and it can lead to serious complications. It is important for healthcare professionals to be aware of this condition and its various forms in order to provide appropriate diagnosis and treatment.
There are two main types of mastocytoma: cutaneous mastocytoma, which affects the skin, and systemic mastocytosis, which can affect multiple organs throughout the body. Cutaneous mastocytoma typically appears as a firm, raised bump or nodule on the skin, and may be accompanied by itching or other symptoms. Systemic mastocytosis is more serious and can cause a wide range of symptoms, including abdominal pain, diarrhea, fatigue, and anemia.
The exact cause of mastocytoma is not known, but it is believed to be linked to genetic mutations and environmental factors such as exposure to toxins or allergens. Diagnosis is typically made through a combination of physical examination, biopsy, and laboratory tests. Treatment options for mastocytoma include surgery, chemotherapy, and medications to reduce histamine levels.
Prognosis for mastocytoma varies depending on the type and severity of the disease, but in general, the prognosis is good for most patients with this condition. With proper treatment, many patients can achieve long-term remission or even be cured. However, in some cases, mastocytoma can progress to more aggressive forms of cancer, such as mast cell leukemia, which can be difficult to treat and has a poorer prognosis.
There is no specific treatment for poxviridae infections, but antiviral medications may be used in some cases. Vaccination against smallpox, which is caused by the variola virus, a member of the poxviridae family, has been widely used to prevent this disease and has been declared eradicated by the World Health Organization (WHO). However, other poxviridae infections remain a significant public health concern, particularly in areas where there is limited access to medical care.
Prevention of poxviridae infections involves avoiding contact with infected animals or people, wearing protective clothing and equipment, and practicing good hygiene. In addition, vaccination against specific poxviridae infections, such as monkeypox and cowpox, may be recommended for certain individuals who are at high risk of infection.
Overall, while the eradication of smallpox is a significant achievement, there remains much work to be done to prevent and control poxviridae infections, particularly in areas with limited access to medical care.
Types of experimental neoplasms include:
* Xenografts: tumors that are transplanted into animals from another species, often humans.
* Transgenic tumors: tumors that are created by introducing cancer-causing genes into an animal's genome.
* Chemically-induced tumors: tumors that are caused by exposure to certain chemicals or drugs.
The use of experimental neoplasms in research has led to significant advances in our understanding of cancer biology and the development of new treatments for the disease. However, the use of animals in cancer research is a controversial topic and alternatives to animal models are being developed and implemented.
2. Our research focuses on identifying the genetic mutations that contribute to experimental melanoma and developing targeted therapies.
3. The patient's experimental melanoma had spread to her lungs and liver, so we recommended chemotherapy and immunotherapy treatments.
The tumor cells are typically small, uniform, and well-differentiated, with a distinct cell border and a central nucleus. The tumor cells are often arranged in a glandular or tubular pattern, which is characteristic of this type of cancer.
Carcinoma, Lewis lung usually affects older adults, with the median age at diagnosis being around 60 years. Men are slightly more likely to be affected than women. The main risk factor for developing this type of cancer is smoking, although it can also occur in people who have never smoked.
The symptoms of Carcinoma, Lewis lung can vary depending on the location and size of the tumor, but they may include:
* Chest pain or discomfort
* Coughing up blood
* Shortness of breath
* Fatigue
* Weight loss
If you suspect you may have Carcinoma, Lewis lung or are experiencing any of these symptoms, it is important to consult a healthcare professional for an accurate diagnosis and appropriate treatment.
The post Definition of 'Carcinoma, Lewis Lung' in the medical field appeared first on Healthy Life Tips.
Neoplastic metastasis can occur in any type of cancer but are more common in solid tumors such as carcinomas (breast, lung, colon). It is important for cancer diagnosis and prognosis because metastasis indicates that the cancer has spread beyond its original site and may be more difficult to treat.
Metastases can appear at any distant location but commonly found sites include the liver, lungs, bones, brain, and lymph nodes. The presence of metastases indicates a higher stage of cancer which is associated with lower survival rates compared to localized cancer.
1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.
2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.
3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.
4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.
5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.
6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.
7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.
8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.
9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.
10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.
Neoplasm refers to an abnormal growth of cells that can be benign (non-cancerous) or malignant (cancerous). Neoplasms can occur in any part of the body and can affect various organs and tissues. The term "neoplasm" is often used interchangeably with "tumor," but while all tumors are neoplasms, not all neoplasms are tumors.
Types of Neoplasms
There are many different types of neoplasms, including:
1. Carcinomas: These are malignant tumors that arise in the epithelial cells lining organs and glands. Examples include breast cancer, lung cancer, and colon cancer.
2. Sarcomas: These are malignant tumors that arise in connective tissue, such as bone, cartilage, and fat. Examples include osteosarcoma (bone cancer) and soft tissue sarcoma.
3. Lymphomas: These are cancers of the immune system, specifically affecting the lymph nodes and other lymphoid tissues. Examples include Hodgkin lymphoma and non-Hodgkin lymphoma.
4. Leukemias: These are cancers of the blood and bone marrow that affect the white blood cells. Examples include acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
5. Melanomas: These are malignant tumors that arise in the pigment-producing cells called melanocytes. Examples include skin melanoma and eye melanoma.
Causes and Risk Factors of Neoplasms
The exact causes of neoplasms are not fully understood, but there are several known risk factors that can increase the likelihood of developing a neoplasm. These include:
1. Genetic predisposition: Some people may be born with genetic mutations that increase their risk of developing certain types of neoplasms.
2. Environmental factors: Exposure to certain environmental toxins, such as radiation and certain chemicals, can increase the risk of developing a neoplasm.
3. Infection: Some neoplasms are caused by viruses or bacteria. For example, human papillomavirus (HPV) is a common cause of cervical cancer.
4. Lifestyle factors: Factors such as smoking, excessive alcohol consumption, and a poor diet can increase the risk of developing certain types of neoplasms.
5. Family history: A person's risk of developing a neoplasm may be higher if they have a family history of the condition.
Signs and Symptoms of Neoplasms
The signs and symptoms of neoplasms can vary depending on the type of cancer and where it is located in the body. Some common signs and symptoms include:
1. Unusual lumps or swelling
2. Pain
3. Fatigue
4. Weight loss
5. Change in bowel or bladder habits
6. Unexplained bleeding
7. Coughing up blood
8. Hoarseness or a persistent cough
9. Changes in appetite or digestion
10. Skin changes, such as a new mole or a change in the size or color of an existing mole.
Diagnosis and Treatment of Neoplasms
The diagnosis of a neoplasm usually involves a combination of physical examination, imaging tests (such as X-rays, CT scans, or MRI scans), and biopsy. A biopsy involves removing a small sample of tissue from the suspected tumor and examining it under a microscope for cancer cells.
The treatment of neoplasms depends on the type, size, location, and stage of the cancer, as well as the patient's overall health. Some common treatments include:
1. Surgery: Removing the tumor and surrounding tissue can be an effective way to treat many types of cancer.
2. Chemotherapy: Using drugs to kill cancer cells can be effective for some types of cancer, especially if the cancer has spread to other parts of the body.
3. Radiation therapy: Using high-energy radiation to kill cancer cells can be effective for some types of cancer, especially if the cancer is located in a specific area of the body.
4. Immunotherapy: Boosting the body's immune system to fight cancer can be an effective treatment for some types of cancer.
5. Targeted therapy: Using drugs or other substances to target specific molecules on cancer cells can be an effective treatment for some types of cancer.
Prevention of Neoplasms
While it is not always possible to prevent neoplasms, there are several steps that can reduce the risk of developing cancer. These include:
1. Avoiding exposure to known carcinogens (such as tobacco smoke and radiation)
2. Maintaining a healthy diet and lifestyle
3. Getting regular exercise
4. Not smoking or using tobacco products
5. Limiting alcohol consumption
6. Getting vaccinated against certain viruses that are associated with cancer (such as human papillomavirus, or HPV)
7. Participating in screening programs for early detection of cancer (such as mammograms for breast cancer and colonoscopies for colon cancer)
8. Avoiding excessive exposure to sunlight and using protective measures such as sunscreen and hats to prevent skin cancer.
It's important to note that not all cancers can be prevented, and some may be caused by factors that are not yet understood or cannot be controlled. However, by taking these steps, individuals can reduce their risk of developing cancer and improve their overall health and well-being.
1. Tumor size and location: Larger tumors that have spread to nearby tissues or organs are generally considered more invasive than smaller tumors that are confined to the original site.
2. Cellular growth patterns: The way in which cancer cells grow and divide can also contribute to the overall invasiveness of a neoplasm. For example, cells that grow in a disorganized or chaotic manner may be more likely to invade surrounding tissues.
3. Mitotic index: The mitotic index is a measure of how quickly the cancer cells are dividing. A higher mitotic index is generally associated with more aggressive and invasive cancers.
4. Necrosis: Necrosis, or the death of cells, can be an indication of the level of invasiveness of a neoplasm. The presence of significant necrosis in a tumor is often a sign that the cancer has invaded surrounding tissues and organs.
5. Lymphovascular invasion: Cancer cells that have invaded lymphatic vessels or blood vessels are considered more invasive than those that have not.
6. Perineural invasion: Cancer cells that have invaded nerve fibers are also considered more invasive.
7. Histological grade: The histological grade of a neoplasm is a measure of how abnormal the cancer cells look under a microscope. Higher-grade cancers are generally considered more aggressive and invasive than lower-grade cancers.
8. Immunohistochemical markers: Certain immunohistochemical markers, such as Ki-67, can be used to evaluate the proliferative activity of cancer cells. Higher levels of these markers are generally associated with more aggressive and invasive cancers.
Overall, the degree of neoplasm invasiveness is an important factor in determining the likelihood of the cancer spreading to other parts of the body (metastasizing) and in determining the appropriate treatment strategy for the patient.
Chorioallantoic membrane
Philip Lazarovici
Smallpox
Smallpox vaccine
Satyavati Motiram Sirsat
Placentation
1931 in science
Virology
History of virology
Introduction to viruses
SULF1
History of coronavirus
In ovo
Vascular endothelial growth factor C
William A. Wimsatt
Chorion
Michael Jeltsch
Chicken as biological research model
Alice Miles Woodruff
Preben von Magnus
Proteases in angiogenesis
Raccoonpox virus
Lumpy skin disease
Influenza vaccine
Thrombospondin 1
Cucurbitacin E
Membrane (disambiguation)
Keith Dumbell
List of MeSH codes (A16)
Mary Logan Reddick
Interferon
Placenta
Draize test
List of MeSH codes (A10)
Index of oncology articles
Cam (disambiguation)
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays
Molecules | Free Full-Text | Melissa officinalis L. Aqueous Extract Exerts Antioxidant and Antiangiogenic Effects and Improves...
Chorioallantoic membrane assay revealed the role of TIPARP (2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible poly (ADP-ribose)...
IKOSA® CAM Assay Application to Quantify Blood Vessels on Chick Chorioallantoic Membrane (CAM)
ArboCat Virus: Junin (JUNV)
The synergic effect of glycyrrhizic acid and low frequency electromagnetic field on angiogenesis in chick chorioallantoic...
The human skin/chick chorioallantoic membrane model accurately predicts the potency of cosmetic allergens<...
Commentary
| Leukemia
Chorioallantoic membrane assays have been based on diffusion control-Problems arising with a diversity of mass transfers in egg...
Evaluation of the tissue toxicity of antiseptics by the hen's egg test on the chorioallantoic membrane (HETCAM) | European...
Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells | Oncotarget
Biomarkers Search
Human vaccinia-like virus outbreaks in São Paulo and Goiás States, Brazil: virus detection, isolation and identification -...
Protocols and Video Articles Authored by Andrew G. Sikora
IndexCat
Consensus guidelines for the use and interpretation of angiogenesis assays - PubMed
MESH TREE NUMBER CHANGES - 2008 MeSH
Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer
Poxviruses Workup: Laboratory Studies, Other Tests, Histologic Findings
Biomarkers Search
PA-07-069: Mechanisms of Alcohol-Associated Cancers (R01)
Prof. dr. W.J. (Wybren Jan) Buma - University of Amsterdam
PA-06-270: Mechanisms of Alcohol-Associated Cancers (R21)
NIOSHTIC-2 Search Results - Full View
Search Results for Most Frequently Published Journals (Superfund Research Program) (Superfund Research Program)
Assay3
- Chorioallantoic Membrane (HET-CAM) assay. (nih.gov)
- WC-Co nanoparticles also induced angiogenesis as determined by the chicken chorioallantoic membrane (CAM) assay. (cdc.gov)
- Chick chorioallantoic membrane assay was carried out to examine the angiogenic potential of the chitosan binder combined with/without hMSCs. (qmul.ac.uk)
Embryo Chorioallantoic Membrane1
- The oxygen sensitivity and phototoxicity of [Ru(Phen)] in chicken embryo chorioallantoic membrane was investigated. (sigmaaldrich.com)
Hen's egg test1
- The vascular irritation was evaluated by the hen's egg test (HET) on the chorioallantoic membrane (CAM). (biomedcentral.com)
Vivo5
- The effects on the vessels of a mucous membrane were directly assessed by stereomicroscopic observation in vivo. (biomedcentral.com)
- In addition, comparative in vivo studies will be performed on intestinal epithelial cells and tissues in an animal model of the chorioallantoic membrane (CAM) of chicken eggs. (nmi.de)
- Collin-Osdoby, P., Rothe, L., Becker, S., Anderson, F., Osdoby, P. (2000) Decreased nitric oxide levels promote osteoclast formation and bone resorption in chick bone marrow and isolated osteoclast cultures in vitro as well as in vivo on the chick chorioallantoic membrane in conjunction with neoangiogenesis. (wustl.edu)
- His work deals with themes such as Molecular biology, Chorioallantoic membrane, In vivo and Ribonuclease, which intersect with Angiogenin. (research.com)
- We have also observed a marked anti-angiogenic effect of CAI in vivo, in chicken chorioallantoic membrane (CAM) assays. (nih.gov)
Assays1
- Moreover, RANTES promotes the expression of matrix metalloproteinase (MMP) 9 by THP-1 monocytic cells and elevates vascularity in chick chorioallantoic membrane assays. (nih.gov)
Chick3
- The inhibitory effect of low frequency electromagnetic field (50Hz) on angiogenesis in chorioalantoic membrane of chick. (ac.ir)
- The chorioallantoic membrane (CAM) of the chick egg has been extensively used for the growth of normal and transformed mammalian tissues. (biu.ac.il)
- This photograph reveals smallpox virus pocks on the chorioallantoic membrane (CAM) of a developing embryonic chick. (cdc.gov)
Extra-embryonic2
- A highly vascularized extra-embryonic membrane, formed by the fusion of the CHORION and the ALLANTOIS . (nih.gov)
- It lies between two other extra-embryonic membranes, the AMNION and the CHORION. (bvsalud.org)
Eggs1
- Variola and vaccinia can be cultured in vitro on chorioallantoic membranes of eggs and in tissue culture. (medscape.com)
Cells1
- Epidermal cells develop ballooning degeneration, and intraepithelial multiloculated vesicles develop by rupture of cellular membranes in the stratum spinosum. (medscape.com)
Test1
- Hen's egg chorioallantoic membrane (HET-CAM) test was used for the evaluation of ocular tolerance, which showed the non-irritant efficacy of the developed formulation. (ijpsr.com)
Samples2
- On the 12th day, the images of chorioallantoic membrane samples were prepared using photostreomicroscope and the number and length of vessels were measured. (ac.ir)
- Endometrial and chorioallantoic membrane samples were collected from healthy and arresting conceptus attachment sites at gestation day (gd) 20 (n = 8) and gd 50 (n = 8). (biomedcentral.com)
Highly1
- Xenograft tumors can be grown rapidly on a highly vascularized structure known as the chorioallantoic membrane (CAM). (bmrat.org)
Assay9
- Here, we established the chick-embryo chorioallantoic (CAM) assay as an affordable and time efficient xenograft model for testing a variety of treatment approaches for DIPG. (nih.gov)
- Tube formation assay and chorioallantoic membranes assay were used to assess tumor angiogenesis. (nih.gov)
- Chorioallantoic Membrane (HET-CAM) assay. (nih.gov)
- 1. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents. (nih.gov)
- 3. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay. (nih.gov)
- 4. The chick embryo chorioallantoic membrane (CAM) assay. (nih.gov)
- 9. Depletion of Embryonic Macrophages Leads to a Reduction in Angiogenesis in the Ex Ovo Chick Chorioallantoic Membrane Assay. (nih.gov)
- 15. Chorioallantoic Membrane Assay as Model for Angiogenesis in Tissue Engineering: Focus on Stem Cells. (nih.gov)
- WC-Co nanoparticles also induced angiogenesis as determined by the chicken chorioallantoic membrane (CAM) assay. (cdc.gov)
Chicken chorioallantoic membrane1
- 20. In ovo administration of human recombinant leptin shows dose dependent angiogenic effect on chicken chorioallantoic membrane. (nih.gov)